4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-20-024878
VP and Chief Compliance Office acquired 4,000 shares (grant or award)
- VP and Chief Compliance Office gave up 1,173 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Herman James L VP and Chief Compliance Office | 2020-03-18 | Shares withheld for taxes | −1,173 | $3.53 | $4,141 | 40,561 | D |
| Herman James L VP and Chief Compliance Office | 2020-03-23 | Grant or award | +4,000 | $3.56 | $14,240 | 44,561 | D |
Loading xslF345X03/doc4.xml…